Status: Not yet recruiting

Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease

A Study on the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis

Participants needed: 54

Trial details

Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.Updated: Mar 5, 2026

Eligibility criteria

Diabetic nephropathy with estimated glomerular filtration rate (eGFR) < 15 mL/mi... [+3]

Patients with conditions unsuitable for AVF, including surgical site infection,... [+6]

Status: Recruiting

Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis

This is a prospective, multi-center, single-arm target value clinical study to study the safety and effectiveness of Peripheral Scoring Drug-coated Balloon dilatation catheters in the treatment of hemodialysis arteriovenous fistula stenosis.

Participants needed: 328

Trial details

Age: 18-80Biological sex: AllType: InterventionalSponsor: DK Medical Technology (Suzhou) Co., Ltd.Updated: Jan 9, 2025Locations: 33

Eligibility criteria

Age ≥ 18 and ≤ 80 years old; [+6]

Women of childbearing age whose preoperative pregnancy test is not negative, and... [+11]

Status: Recruiting

Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis

To compare the access circuit primary patency after Ranger drug-coated balloon angioplasty of arteriovenous fistula (AVF) stenosis with that after conventional balloon angioplasty

Participants needed: 94

Trial details

Phase: Phase 3Age: 21+Biological sex: AllType: InterventionalSponsor: Singapore General HospitalUpdated: Aug 14, 2024Locations: 1

Eligibility criteria

Failing AVF with at least 1 AVF stenosis presenting with any clinical, physiolog... [+4]

Thrombosed AVFs [+9]